LDS/Medical Tests/Human Papilloma Virus (HPV) for Oral Cancer (Oral HPV)

Human Papilloma Virus (HPV) for Oral Cancer (Oral HPV)

Oral cancer is a definite concern among men. The HPV virus is a known risk factor and causative agent in oral cancers. Statistics show that oral cancer is ranked eighth as the most common cancer in men. There are approximately 34,000 oropharyngeal cancers diagnosed each year of which 50% are suspected to be caused by HPV virus. An HPV infected individual has up to a 32-fold risk of developing oral cancer compared to those who do not have the HPV virus. Traditionally the diagnosis of oral cancer has been by the examination of the lips, tongue, and mouth areas for lesions or other abnormalities that would implicate a cancerous growth. Also, a history of alcohol or tobacco use are associated with a higher incidence of oropharyngeal cancer.

Human Papilloma virus (i.e. HPV) is the most common non-reportable sexually transmitted infection in the United States. HPV is a member of the papilloma virus family, which contains greater than 200 different HPV types. HPV causes a wide range of infections including common and genital warts, genital and anal cancers as well as oropharyngeal cancer (sometimes referred to as head and neck cancer).

The types of HPV that infect the genital tract are divided into two risk categories based on their association with causing cervical cancers. Types that are rarely associated with cancers, but cause other genital infections are classified as low-risk types and include types 6 and 11, which cause genital warts (i.e., condylomas). High-risk types are those that have been shown to have a strong association with cervical cancers. These include types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, and 82. Although most HPV infections resolve spontaneously without treatment, those that persist result in substantial morbidity and invoke high costs associated with the treatment of clinically relevant lesions.

The OraRisk HPV test utilizes the collection of saliva to determine the presence and type of HPV. This test is used to help the provider evaluate for the risk or presence of oral cancer in suspected individuals.

  • Screening for oral cancer and precancer (head and neck cancer)
  • As an aid in diagnosis of oral cancer (head and neck cancer)
  • Disease management and treatment selection
  • Asymptomatic patients who test positive for HPV can be determined to be at low or high risk of developing cancer
  • Symptomatic patients or patients with disease can be monitored to follow the effectiveness of the course of treatment. Early treatment can result in better outcomes

Negative (Not detected)

Real time Polymerase Chain Reaction (PCR), Hybrid Capture (hybridization with signal amplification technology), Transcription mediated technology (TMA).

Buccal swab, Saliva, Mouth wash and male urine.

Collect saliva by via saline gargle or swishing. Expel fluid into funneled collection tube and cap.

Collect buccal swab by scraping and rotating the swab vigorously on left side of the cheek for 20-30 seconds. Immediately after collecting buccal sample, put the swab onto the folded sample envelope to dry or in the collection media (viral media).

Collect mouth wash by rinsing mouth several times with mouth wash solution

Specimen Stability

All specimens should be refrigerated.
Stable up to 7 days refrigerated.

PAP smear (cytology testing) if female, HPV 16/18 genotyping, High risk HPV full genotyping, cervical biopsy if female, anal biopsy, q3 chromosomal abnormality by FISH, oral biopsy.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login